13.14. Analysis.
Comparison 13 Intramuscular prostaglandin versus injectable uterotonics (subgroups by low‐ and high‐risk pregnancy), Outcome 14 Diarrhoea.
Comparison 13 Intramuscular prostaglandin versus injectable uterotonics (subgroups by low‐ and high‐risk pregnancy), Outcome 14 Diarrhoea.